科研製薬（4521）のセグメントごとの売上高・利益等
セグメント通期
- 【有報】
- セグメント情報等、連結財務諸表
| 科目 | 年度 | 薬業 | 不動産事業 |
|---|---|---|---|
| 売上高 | 2013/03 | 846億 | 24.4億 |
| 2014/03 | 865億 +2.2% | 24.6億 +1.1% | |
| 2015/03 | 915億 +5.8% | 24.3億 -1.3% | |
| 2016/03 | 1074億 +17.4% | 23.4億 -3.8% | |
| 2017/03 | 991億 -7.7% | 23.9億 +2.1% | |
| 2018/03 | 960億 -3.1% | 24.1億 +0.9% | |
| 2019/03 | 918億 -4.4% | 23.6億 -2% | |
| 2020/03 | 869億 -5.4% | 23.8億 +0.8% | |
| 2021/03 | 726億 -16.4% | 23.7億 -0.5% | |
| 2022/03 | 736億 +1.4% | 24.1億 +1.9% | |
| 2023/03 | 706億 -4.2% | 24.2億 +0.5% | |
| 2024/03 | 696億 -1.3% | 24.3億 +0.3% | |
| 2025/03 | 916億 +31.5% | 24.8億 +2.1% | |
| 科目 | 年度 | 薬業 | 不動産事業 |
| 営業利益 | 2013/03 | 132億 | 13.7億 |
| 2014/03 | 144億 +9% | 14.5億 +5.5% | |
| 2015/03 | 193億 +33.6% | 13.6億 -6% | |
| 2016/03 | 336億 +74.5% | 15.1億 +11.4% | |
| 2017/03 | 291億 -13.5% | 16.3億 +7.7% | |
| 2018/03 | 258億 -11.1% | 16.6億 +1.6% | |
| 2019/03 | 231億 -10.5% | 14.8億 -10.8% | |
| 2020/03 | 250億 +8.4% | 14.6億 -0.9% | |
| 2021/03 | 164億 -34.6% | 14.2億 -3.1% | |
| 2022/03 | 157億 -4% | 13.5億 -4.6% | |
| 2023/03 | 67.1億 -57.3% | 12.9億 -4.7% | |
| 2024/03 | 81.4億 +21.4% | 13.7億 +6.4% | |
| 2025/03 | 197億 +141.5% | 13.8億 +0.1% | |
| 科目 | 年度 | 薬業 | 不動産事業 |
| 営業利益率 | 2013/03 | 15.6% | 56.3% |
| 2014/03 | 16.7% +1.1% | 58.7% +2.4% | |
| 2015/03 | 21.1% +4.4% | 55.9% -2.8% | |
| 2016/03 | 31.3% +10.2% | 64.7% +8.8% | |
| 2017/03 | 29.3% -2% | 68.3% +3.6% | |
| 2018/03 | 26.9% -2.4% | 68.8% +0.5% | |
| 2019/03 | 25.2% -1.7% | 62.5% -6.3% | |
| 2020/03 | 28.8% +3.6% | 61.5% -1% | |
| 2021/03 | 22.5% -6.3% | 60% -1.5% | |
| 2022/03 | 21.3% -1.2% | 56.1% -3.9% | |
| 2023/03 | 9.5% -11.8% | 53.3% -2.8% | |
| 2024/03 | 11.7% +2.2% | 56.5% +3.2% | |
| 2025/03 | 21.5% +9.8% | 55.4% -1.1% | |
| 科目 | 年度 | 薬業 | 不動産事業 |
| 研究開発費 | 2013/03 | - | - |
| 2014/03 | - | - | |
| 2015/03 | - | - | |
| 2016/03 | - | - | |
| 2017/03 | - | - | |
| 2018/03 | - | - | |
| 2019/03 | 103億 | - | |
| 2020/03 | 64.2億 -37.5% | - | |
| 2021/03 | 67.4億 +5% | - | |
| 2022/03 | 84.2億 +25% | - | |
| 2023/03 | 158億 +87.5% | - | |
| 2024/03 | 125億 -20.6% | - | |
| 2025/03 | 187億 +49.3% | - | |
| 科目 | 年度 | 薬業 | 不動産事業 |
| 設備投資額 | 2013/03 | - | - |
| 2014/03 | - | - | |
| 2015/03 | - | - | |
| 2016/03 | - | - | |
| 2017/03 | - | - | |
| 2018/03 | - | - | |
| 2019/03 | 22.9億 | 19百万 | |
| 2020/03 | 13.3億 -41.6% | 43百万 +126.3% | |
| 2021/03 | 18.6億 +39.6% | 274百万 +537.2% | |
| 2022/03 | 30億 +61.3% | 506百万 +84.7% | |
| 2023/03 | 19.5億 -34.9% | 14百万 -97.2% | |
| 2024/03 | 23億 +17.5% | 8百万 -42.9% | |
| 2025/03 | 33.7億 +46.8% | 48百万 +500% | |
| 科目 | 年度 | 薬業 | 不動産事業 |
| 固定資産増加額 | 2013/03 | 34.4億 | 10.8億 |
| 2014/03 | 17.8億 -48.2% | 0.6億 -94.4% | |
| 2015/03 | 29.2億 +63.7% | 0.2億 -66.7% | |
| 2016/03 | 31.2億 +6.8% | 0.2億 ±0% | |
| 2017/03 | 16億 -48.5% | 0.87億 +335% | |
| 2018/03 | 29.3億 +82.8% | 0.41億 -52.9% | |
| 2019/03 | 64.1億 +118.5% | 0.19億 -53.7% | |
| 2020/03 | 16.8億 -73.8% | 0.44億 +131.6% | |
| 2021/03 | 24.4億 +45.4% | 2.87億 +552.3% | |
| 2022/03 | 113億 +364.7% | 5.08億 +77% | |
| 2023/03 | 27.7億 -75.6% | 0.19億 -96.3% | |
| 2024/03 | 79.4億 +186.5% | 0.08億 -57.9% | |
| 2025/03 | 172億 +116.9% | 0.56億 +600% | |
| 科目 | 年度 | 薬業 | 不動産事業 |
| 従業員数 | 2013/03 | - | - |
| 2014/03 | - | - | |
| 2015/03 | - | - | |
| 2016/03 | - | - | |
| 2017/03 | - | - | |
| 2018/03 | - | - | |
| 2019/03 | 1,341 | - | |
| 2020/03 | 1,268 -5.4% | - | |
| 2021/03 | 1,215 -4.2% | - | |
| 2022/03 | 1,164 -4.2% | - | |
| 2023/03 | 1,129 -3% | 1 | |
| 2024/03 | 1,134 +0.4% | 1 ±0% | |
| 2025/03 | 1,125 -0.8% | 1 ±0% | |
| 科目 | 年度 | 薬業 | 不動産事業 |
| 平均臨時雇用人員 | 2013/03 | - | - |
| 2014/03 | - | - | |
| 2015/03 | - | - | |
| 2016/03 | - | - | |
| 2017/03 | - | - | |
| 2018/03 | - | - | |
| 2019/03 | 261 | 1 | |
| 2020/03 | 241 -7.7% | 1 ±0% | |
| 2021/03 | 224 -7.1% | 1 ±0% | |
| 2022/03 | 212 -5.4% | 1 ±0% | |
| 2023/03 | 194 -8.5% | - | |
| 2024/03 | 173 -10.8% | - | |
| 2025/03 | 171 -1.2% | - | |
| 科目 | 年度 | 薬業 | 不動産事業 |
| 資産 | 2013/03 | 681億 | 172億 |
| 2014/03 | 647億 -5% | 166億 -3.4% | |
| 2015/03 | 720億 +11.4% | 114億 -31.5% | |
| 2016/03 | 752億 +4.5% | 111億 -2.9% | |
| 2017/03 | 769億 +2.2% | 108億 -2.2% | |
| 2018/03 | 854億 +11.1% | 106億 -2.4% | |
| 2019/03 | 819億 -4.1% | 103億 -2.6% | |
| 2020/03 | 696億 -15% | 100億 -2.5% | |
| 2021/03 | 717億 +3% | 102億 +1.8% | |
| 2022/03 | 756億 +5.5% | 104億 +1.8% | |
| 2023/03 | 742億 -1.8% | 101億 -2.9% | |
| 2024/03 | 860億 +15.9% | 97.8億 -3.1% | |
| 2025/03 | 1002億 +16.5% | 113億 +15.4% | |
| 科目 | 年度 | 薬業 | 不動産事業 |
| 減損損失 | 2013/03 | - | - |
| 2014/03 | - | - | |
| 2015/03 | - | - | |
| 2016/03 | - | - | |
| 2017/03 | - | - | |
| 2018/03 | - | - | |
| 2019/03 | - | - | |
| 2020/03 | 2.87億 | - | |
| 2021/03 | - | - | |
| 2022/03 | 29.9億 | - | |
| 2023/03 | 18.6億 -37.8% | - | |
| 2024/03 | 0.19億 -99% | - | |
| 2025/03 | 14.9億 +999.99% | - | |
| 科目 | 年度 | 薬業 | 不動産事業 |
| のれん | 2013/03 | - | - |
| 2014/03 | - | - | |
| 2015/03 | - | - | |
| 2016/03 | - | - | |
| 2017/03 | - | - | |
| 2018/03 | - | - | |
| 2019/03 | - | - | |
| 2020/03 | - | - | |
| 2021/03 | - | - | |
| 2022/03 | 3.12億 | - | |
| 2023/03 | 2.3億 -26.3% | - | |
| 2024/03 | 9.37億 +307.4% | - | |
| 2025/03 | 140億 +999.99% | - | |
| 科目 | 年度 | 薬業 | 不動産事業 |
| のれん償却額 | 2013/03 | - | - |
| 2014/03 | - | - | |
| 2015/03 | - | - | |
| 2016/03 | - | - | |
| 2017/03 | - | - | |
| 2018/03 | - | - | |
| 2019/03 | - | - | |
| 2020/03 | - | - | |
| 2021/03 | - | - | |
| 2022/03 | 5百万 | - | |
| 2023/03 | 22百万 +340% | - | |
| 2024/03 | 157百万 +613.6% | - | |
| 2025/03 | 79百万 -49.7% | - |
セグメント四半期
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
|---|---|---|---|---|---|---|
| 薬業 | ||||||
| 売上高 1Q2Q 3Q | 2014/03 | 206億 | 218億 | 227億 | 213億 | 865億 |
| 2015/03 | 209億 +1% | 222億 +1.5% | 263億 +16% | 221億 +3.8% | 915億 +5.8% | |
| 2016/03 | 270億 +29.6% | 268億 +20.8% | 299億 +13.5% | 237億 +7.2% | 1074億 +17.4% | |
| 2017/03 | 256億 -5.2% | 254億 -5.3% | 262億 -12.4% | 219億 -7.6% | 991億 -7.7% | |
| 2018/03 | 244億 -4.9% | 243億 -4.2% | 264億 +1% | 209億 -4.5% | 960億 -3.1% | |
| 2019/03 | 236億 -3.3% | 228億 -6.1% | 245億 -7.5% | 210億 +0.3% | 918億 -4.4% | |
| 2020/03 | 217億 -7.7% | 222億 -2.5% | 244億 -0.2% | 185億 -12% | 869億 -5.4% | |
| 2021/03 | 175億 -19.6% | 181億 -18.5% | 197億 -19.3% | 173億 -6.3% | 726億 -16.4% | |
| 2022/03 | 179億 +2.2% | 185億 +2.2% | 195億 -1% | 177億 +2.4% | 736億 +1.4% | |
| 2023/03 | 176億 -1.6% | 180億 -2.8% | 182億 -7% | 168億 -5.1% | 706億 -4.2% | |
| 2024/03 | 175億 -0.2% | 174億 -3.4% | 179億 -1.4% | 167億 -0.4% | 696億 -1.3% | |
| 営業利益 1Q2Q 3Q | 2014/03 | 31.2億 | 35.2億 | 41.1億 | 36.8億 | 144億 |
| 2015/03 | 37.2億 +19.3% | 43.6億 +23.7% | 74.4億 +81.1% | 37.6億 +2.2% | 193億 +33.6% | |
| 2016/03 | 88.4億 +137.8% | 88.3億 +102.8% | 109億 +46.2% | 51億 +35.4% | 336億 +74.5% | |
| 2017/03 | 76.9億 -13% | 76.2億 -13.7% | 84.2億 -22.5% | 53.5億 +4.9% | 291億 -13.5% | |
| 2018/03 | 72.3億 -6% | 72.7億 -4.6% | 79.6億 -5.4% | 33.7億 -36.9% | 258億 -11.1% | |
| 2019/03 | 52.8億 -27% | 63.5億 -12.7% | 71.7億 -10% | 43.2億 +28.1% | 231億 -10.5% | |
| 2020/03 | 63.4億 +20.1% | 66.7億 +5% | 83.2億 +16.1% | 37.2億 -13.9% | 250億 +8.4% | |
| 2021/03 | 46.9億 -26% | 44億 -34.1% | 48.1億 -42.2% | 24.7億 -33.5% | 164億 -34.6% | |
| 2022/03 | 41.2億 -12.1% | 42.8億 -2.7% | 44.9億 -6.7% | 28.2億 +14.1% | 157億 -4% | |
| 2023/03 | 37.6億 -8.8% | 38.3億 -10.5% | 38.4億 -14.5% | -47.3億 赤字 | 67.1億 -57.3% | |
| 2024/03 | 29.7億 -21% | 18.8億 -51% | 30.1億 -21.7% | 2.82億 | 81.4億 +21.4% | |
| 営業利益率 | 2014/03 | 15.1% | 16.1% | 18.1% | 17.3% | 16.7% |
| 2015/03 | 17.8% +2.7% | 19.7% +3.6% | 28.3% +10.2% | 17% -0.3% | 21.1% +4.4% | |
| 2016/03 | 32.7% +14.9% | 33% +13.3% | 36.4% +8.1% | 21.5% +4.5% | 31.3% +10.2% | |
| 2017/03 | 30% -2.7% | 30.1% -2.9% | 32.1% -4.3% | 24.4% +2.9% | 29.3% -2% | |
| 2018/03 | 29.7% -0.3% | 29.9% -0.2% | 30.1% -2% | 16.1% -8.3% | 26.9% -2.4% | |
| 2019/03 | 22.4% -7.3% | 27.9% -2% | 29.3% -0.8% | 20.6% +4.5% | 25.2% -1.7% | |
| 2020/03 | 29.2% +6.8% | 30% +2.1% | 34.1% +4.8% | 20.1% -0.5% | 28.8% +3.6% | |
| 2021/03 | 26.8% -2.4% | 24.3% -5.7% | 24.4% -9.7% | 14.3% -5.8% | 22.5% -6.3% | |
| 2022/03 | 23.1% -3.7% | 23.1% -1.2% | 23% -1.4% | 15.9% +1.6% | 21.3% -1.2% | |
| 2023/03 | 21.4% -1.7% | 21.3% -1.8% | 21.2% -1.8% | -28.1% 赤字 | 9.5% -11.8% | |
| 2024/03 | 16.9% -4.5% | 10.8% -10.5% | 16.8% -4.4% | 1.7% | 11.7% +2.2% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 不動産事業 | ||||||
| 売上高 1Q2Q 3Q | 2014/03 | 6.22億 | 6.15億 | 6.14億 | 6.12億 | 24.6億 |
| 2015/03 | 6.12億 -1.6% | 6.14億 -0.2% | 6.03億 -1.8% | 6.02億 -1.6% | 24.3億 -1.3% | |
| 2016/03 | 6億 -2% | 5.78億 -5.9% | 5.78億 -4.1% | 5.82億 -3.3% | 23.4億 -3.8% | |
| 2017/03 | 5.94億 -1% | 5.96億 +3.1% | 5.97億 +3.3% | 5.99億 +2.9% | 23.9億 +2.1% | |
| 2018/03 | 5.99億 +0.8% | 6.02億 +1% | 5.91億 -1% | 6.15億 +2.7% | 24.1億 +0.9% | |
| 2019/03 | 5.83億 -2.7% | 5.83億 -3.2% | 5.98億 +1.2% | 5.96億 -3.1% | 23.6億 -2% | |
| 2020/03 | 5.96億 +2.2% | 5.98億 +2.6% | 5.93億 -0.8% | 5.91億 -0.8% | 23.8億 +0.8% | |
| 2021/03 | 5.85億 -1.8% | 5.93億 -0.8% | 5.94億 +0.2% | 5.93億 +0.3% | 23.7億 -0.5% | |
| 2022/03 | 5.89億 +0.7% | 6.03億 +1.7% | 6.1億 +2.7% | 6.08億 +2.5% | 24.1億 +1.9% | |
| 2023/03 | 6.15億 +4.4% | 6.04億 +0.2% | 6.01億 -1.5% | 6.02億 -1% | 24.2億 +0.5% | |
| 2024/03 | 6.05億 -1.6% | 6.07億 +0.5% | 6.09億 +1.3% | 6.09億 +1.2% | 24.3億 +0.3% | |
| 営業利益 1Q2Q 3Q | 2014/03 | 3.62億 | 3.59億 | 3.65億 | 3.59億 | 14.5億 |
| 2015/03 | 3.68億 +1.7% | 3.66億 +1.9% | 3.69億 +1.1% | 2.55億 -29% | 13.6億 -6% | |
| 2016/03 | 3.95億 +7.3% | 3.8億 +3.8% | 3.78億 +2.4% | 3.6億 +41.2% | 15.1億 +11.4% | |
| 2017/03 | 4.04億 +2.3% | 4.05億 +6.6% | 4.12億 +9% | 4.08億 +13.3% | 16.3億 +7.7% | |
| 2018/03 | 4.14億 +2.5% | 4.12億 +1.7% | 4.11億 -0.2% | 4.18億 +2.5% | 16.6億 +1.6% | |
| 2019/03 | 3.69億 -10.9% | 3.55億 -13.8% | 3.79億 -7.8% | 3.73億 -10.8% | 14.8億 -10.8% | |
| 2020/03 | 3.67億 -0.5% | 3.65億 +2.8% | 3.69億 -2.6% | 3.62億 -2.9% | 14.6億 -0.9% | |
| 2021/03 | 3.41億 -7.1% | 3.51億 -3.8% | 3.57億 -3.3% | 3.69億 +1.9% | 14.2億 -3.1% | |
| 2022/03 | 2.99億 -12.3% | 3.36億 -4.3% | 3.63億 +1.7% | 3.55億 -3.8% | 13.5億 -4.6% | |
| 2023/03 | 2.95億 -1.3% | 3.21億 -4.5% | 3.44億 -5.2% | 3.3億 -7% | 12.9億 -4.7% | |
| 2024/03 | 3.21億 +8.8% | 3.4億 +5.9% | 3.54億 +2.9% | 3.58億 +8.5% | 13.7億 +6.4% | |
| 営業利益率 | 2014/03 | 58.2% | 58.4% | 59.4% | 58.7% | 58.7% |
| 2015/03 | 60.1% +1.9% | 59.6% +1.2% | 61.2% +1.8% | 42.4% -16.3% | 55.9% -2.8% | |
| 2016/03 | 65.8% +5.7% | 65.7% +6.1% | 65.4% +4.2% | 61.9% +19.5% | 64.7% +8.8% | |
| 2017/03 | 68% +2.2% | 68% +2.3% | 69% +3.6% | 68.1% +6.2% | 68.3% +3.6% | |
| 2018/03 | 69.1% +1.1% | 68.4% +0.4% | 69.5% +0.5% | 68% -0.1% | 68.8% +0.5% | |
| 2019/03 | 63.3% -5.8% | 60.9% -7.5% | 63.4% -6.1% | 62.6% -5.4% | 62.5% -6.3% | |
| 2020/03 | 61.6% -1.7% | 61% +0.1% | 62.2% -1.2% | 61.3% -1.3% | 61.5% -1% | |
| 2021/03 | 58.3% -3.3% | 59.2% -1.8% | 60.1% -2.1% | 62.2% +0.9% | 60% -1.5% | |
| 2022/03 | 50.8% -7.5% | 55.7% -3.5% | 59.5% -0.6% | 58.4% -3.8% | 56.1% -3.9% | |
| 2023/03 | 48% -2.8% | 53.1% -2.6% | 57.2% -2.3% | 54.8% -3.6% | 53.3% -2.8% | |
| 2024/03 | 53.1% +5.1% | 56% +2.9% | 58.1% +0.9% | 58.8% +4% | 56.5% +3.2% | |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
